Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
Wang
Sophia S
SS
Interdisciplinary Studies Section, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. wangso@mail.nih.gov
Hildesheim
Allan
A
Gao
Xiaojiang
X
Schiffman
Mark
M
Herrero
Rolando
R
Bratti
M Concepcion
MC
Sherman
Mark E
ME
Barnes
Willard A
WA
Greenberg
Mitchell D
MD
McGowan
Larry
L
Mortel
Rodrigue
R
Schwartz
Peter E
PE
Zaino
Richard J
RJ
Glass
Andrew G
AG
Burk
Robert D
RD
Karacki
Peter
P
Carrington
Mary
M
D000328:Adult; D015331:Cohort Studies; D003364:Costa Rica / Q000453:epidemiology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005805:Genes, MHC Class I / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D019656:Loss of Heterozygosity; D027383:Papillomaviridae / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000150:complications* / Q000517:prevention & control; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D014412:Tumor Virus Infections / Q000150:complications* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000276:immunology / Q000517:prevention & control
D004279:DNA, Viral